Bansisons Tea Industries Limited, now operating as Novyra Pharmachem Limited, has announced its unaudited financial results for the third quarter ended December 31, 2025. The company's Board of Directors approved these results during their meeting held on January 26, 2026, at the registered office in Surat, Gujarat.

Financial Performance Overview

The company reported challenging financial performance for the quarter, with no revenue generation from operations. The financial results show a net loss of ₹1.15 lakhs for Q3 FY26, representing a deterioration from the ₹0.88 lakhs loss recorded in the corresponding quarter of the previous year.

Nine-Month Performance Analysis

For the nine-month period ended December 31, 2025, the company's performance showed mixed results compared to the previous year. While other income increased to ₹6.31 lakhs from nil in the corresponding period last year, total expenses also rose significantly.

Expense Structure and Key Metrics

The company's expense structure for Q3 FY26 comprised employee benefit expenses of ₹0.39 lakhs, depreciation and amortisation expense of ₹0.73 lakhs, and other expenses of ₹0.03 lakhs. The increase in depreciation expenses indicates potential capital investments or asset additions during the period.

Earnings Per Share Performance:

• Basic EPS for Q3 FY26: ₹(0.02)
• Diluted EPS for Q3 FY26: ₹(0.02)
• Nine-month EPS: ₹(0.03)

The company's paid-up equity share capital stands at ₹630.00 lakhs as of December 31, 2025, with a face value of ₹10.00 per share.

Corporate Governance and Compliance

The financial results were reviewed by the Audit Committee before approval by the Board of Directors. The statutory auditors D G M S & Co., Chartered Accountants, conducted a limited review of the unaudited results. The results have been prepared in accordance with Indian Accounting Standard 34 - Interim Financial Reporting, as prescribed under Section 133 of the Companies Act, 2013.

The Board meeting commenced at 5:30 PM and concluded at 7:00 PM on January 26, 2026, with Director Hiren Dhirajlal Shah (DIN: 09842161) signing the results on behalf of the company.

Bansisons Tea Industries Limited has issued a clarification to BSE regarding compliance matters related to its FY2020-21 financial results. The company addressed queries raised by the exchange concerning the non-submission of Declaration on Impact of Audit Qualifications along with its financial statements.

Audit Compliance Clarification

The company clarified that its statutory auditors R.K. Bihani Associates issued an unmodified/unqualified audit report for the financial year ended March 31, 2021. The audit report contained no qualifications, reservations, adverse remarks, or disclaimers of opinion. Consequently, the requirement to submit a Declaration on Impact of Audit Qualifications under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 was not applicable to the company for the said financial year.

The company emphasized that the non-submission of the declaration was inadvertent and without any malafide intent. As advised by BSE officials, the company resubmitted its financial results for FY2020-21 along with the clarification letter to ensure full compliance with exchange requirements.

Financial Performance Overview

The company's financial results for FY2020-21 showed a significant improvement compared to the previous year. Bansisons Tea Industries reported revenue from operations of ₹15.00 lakhs, maintaining the same level as FY2019-20.

The company achieved a turnaround in profitability, recording a net profit of ₹7.89 lakhs in FY2020-21 compared to a net loss of ₹1.79 lakhs in the previous year. This improvement was driven by higher other income and controlled expenses.

Operational Highlights

The company's primary business involves leasing of tea garden for plucking and sale operations. During FY2020-21, the company maintained its operational focus while implementing cost management measures. Employee costs remained stable at ₹2.90 lakhs, while other expenses decreased significantly from ₹11.86 lakhs to ₹6.13 lakhs, contributing to improved profitability.

Balance Sheet Position

As of March 31, 2021, the company maintained a stable financial position with total assets of ₹62.20 lakhs. The company's equity base remained unchanged at ₹61.98 lakhs in share capital, though accumulated losses reduced the overall shareholders' fund to ₹52.71 lakhs.

The company requested BSE to take the clarification on record and treat the matter as complied with, demonstrating its commitment to maintaining transparency and regulatory compliance in its reporting obligations.